Company news
Vertex Pharmaceuticals Incorporated news in 2019
Vertex Pharmaceuticals Incorporated's news releases, calls and decks from 2019, newest first.
Vertex Confirms Northern Ireland Offer Accepted for Cystic Fibrosis Medicines
November 11, 2019
Vertex Reports Third-Quarter 2019 Financial Results
October 29, 2019
Vertex to Announce Third-Quarter 2019 Financial Results on October 30
October 20, 2019
Vertex Receives European CHMP Positive Opinion for KALYDECO® (ivacaftor) to Treat Eligible Infants with Cystic Fibrosis as Early as 6 Months of Age
October 17, 2019
Vertex Appoints Carmen Bozic, M.D., as New Chief Medical Officer and Nia Tatsis, Ph.D., as New Chief Regulatory Officer
September 30, 2019
Vertex Reports Second-Quarter 2019 Financial Results
July 30, 2019
Vertex Appoints Charles Wagner as Chief Financial Officer
April 1, 2019
Calls in 2019
- Vertex Pharmaceuticals (NASDAQ:VRTX) Q3 2019 Earnings Call
Oct 30, 2019
Transcript - Vertex Pharmaceuticals (NASDAQ:VRTX) Q2 2019 Earnings Call
Jul 31, 2019
Transcript - Vertex Pharmaceuticals (NASDAQ:VRTX) Q1 2019 Earnings Call
Apr 30, 2019
Transcript - Vertex Pharmaceuticals (NASDAQ:VRTX) Q4 2018 Earnings Call
Feb 5, 2019
Transcript
Decks in 2019
- FY2018 Earnings Presentation
Earnings · 13 slides · Feb 5, 2019